The MTRR gene helps your body keep a vitamin B12 related enzyme working, so it can recycle a natural body chemical called homocysteine and make methionine, a protein building block. This gene plays an important role in how cells use folate and vitamin B12. If both copies have harmful variants, homocysteine can build up and some people develop a rare inherited condition with anemia, developmental delay, and nerve or brain symptoms. Most common MTRR variants do not cause disease on their own.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the directions for producing proteins, the parts of cells that do the work. Others mainly control where certain processes happen, when they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
MTRRGene function
What if the gene works
The MTRR gene helps keep vitamin B12 in its active form. This supports the recycling of homocysteine into methionine, which your body uses for protein building, cell growth, and making DNA.
Risk
What if the gene does not work
When both copies of the MTRR gene do not work, the body cannot properly use vitamin B12. This can lead to anemia, developmental delay, and nerve or brain problems. Milder and more severe variants can change symptom timing and severity.
Treatment
What does that mean for your treatment
Pathogenic variants in the MTRR gene usually guide treatment toward long term hydroxocobalamin, often with betaine, and sometimes folate support. Nitrous oxide is generally avoided because it can worsen the underlying metabolic problem. These choices aim to lower homocysteine and support blood, nerve, and brain health.
Conditions associated with MTRR
Gene function
What if the gene works
Your cells use the MTRR gene to keep an important vitamin B12 helper ready for action. This supports the pathway that turns homocysteine into methionine, a building block used across the body. Understanding the MTRR gene's function helps you see how cells connect vitamin B12, folate, and everyday metabolism.
The MTRR gene refreshes a vitamin B12 helper after it has been used. This keeps a partner protein ready to continue an important cell reaction.
By keeping that B12 helper active, the MTRR gene supports the step that turns homocysteine into methionine. Methionine helps your body make proteins and carry out many routine chemical tasks.
This gene works closely with the folate pathway, which handles a form of vitamin B9. Together, they help cells transfer small chemical pieces needed for everyday metabolism.
Through this pathway, the MTRR gene supports the supply of compounds used to place small chemical tags on DNA, proteins, and other molecules. These tags help cells adjust gene activity and many routine functions.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help make up normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MTRR gene can make its enzyme unstable, less active, or unable to help recycle active vitamin B12 inside cells. This is the key idea behind how MTRR gene variants affect enzyme activity. Milder missense variants may leave some function, while more severe splice or truncating variants can greatly reduce or stop activity. In the related inherited condition, lower residual activity often goes with earlier symptoms and a wider range of features.
How variants are linked to conditions
Pathogenic variants in the MTRR gene cause methylcobalamin deficiency cblE type, a rare inherited condition that can bring very high homocysteine levels, anemia, developmental delay, seizures, and nerve or eye problems. Among MTRR gene variants linked to conditions, this is the clearest association. Finding disease-causing variants in both copies of the MTRR gene can confirm the diagnosis, while common MTRR changes studied for birth defects or other common illnesses have not shown consistent diagnostic links.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and instead represent natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that clearly increase or reduce health risk related to the MTRR gene. Some changes in MTRR are studied alongside folate, vitamin B12, and other genes that affect homocysteine, but personal risk depends on the full genetic picture and overall health.
Inheritance of MTRR variants
Variants in the MTRR gene linked to MTRR-related homocystinuria are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the MTRR gene from each parent, and parents who carry one copy are typically unaffected carriers. When both parents carry an MTRR gene variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. Because the MTRR gene is on chromosome 5, this MTRR gene inheritance pattern affects males and females equally.
What does my MTRR result mean for my family?
For families affected by disease-causing changes in the MTRR gene, the pattern is usually recessive, which means parents are often healthy carriers. Brothers and sisters may also be affected or may be carriers, and other close relatives could carry the same gene change. Because of that, family members may wish to learn whether carrier or family testing is relevant for them.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the MTRR gene, a lab can do genetic testing for MTRR variants using blood, saliva, or a cheek swab. The test reads your DNA sequence and checks for specific variants. Results can show whether a variant is present, absent, or uncertain in its health meaning.
When should I consider getting a genetic test?
Genetic testing for the MTRR gene may be worth considering when a baby, child, or adult has signs of a rare inherited problem using vitamin B12, such as severe anemia, developmental delay, seizures, or very high homocysteine on blood tests. It can also help if this condition runs in the family or if both parents are known carriers.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic information may help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or uses a drug. This is common and helps explain why the same treatment works well for one person, does less for another, or causes more side effects in someone else. These differences can influence both how effective a medicine feels and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences can shape the way a person responds to medications. It examines relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the MTRR gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, new medicines, or treatment changes are best discussed with your doctor. MTRR has been studied in relation to methotrexate and other folate-related treatments, but the findings are not strong enough to guide routine care.
History
Long before the MTRR gene was identified, doctors had described a rare inherited pattern in some children with high homocysteine levels and features of a vitamin B12 related condition, later called cblE type. From these first observations, research expanded steadily. In the 1990s, scientists mapped and characterized the MTRR gene, linking it to this long recognized condition and helping separate cblE from other inherited B12 pathway conditions. That discovery gave families a clearer genetic explanation and improved laboratory diagnosis. Over time, descriptions became more precise as genetic testing confirmed that different MTRR variants can underlie a similar clinical picture.